Loading institutional data...
Loading institutional data...
No institutional (13F) filings cover this company, so the Overview and 13F tabs are thin. Everything drawn from its SEC filings is here.
Loading snapshot...
Loading financials...
Loading valuation...
Loading analysis...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Ranked against 14 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-09-30.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EXPE | $33.9B | 28.8× | 12.6× | 2.3× | 7.6% | — | 8.8% | 101% | 17.4% | 0.3× | 328 |
| EXPD | $25.8B | 33.3× | 22.1× | 2.3× | 4.4% | — | 7.3% | 34.4% | 34.4% | -1.2× | 274 |
| XPO | $21.4B | 69.3× | 21.7× | 2.6× | 1.1% | — | 3.9% | 17.0% | 6.2% | 2.6× | 173 |
| CHRW | $14.7B | 26.4× | 18.9× | 0.9× | -8.4% | — | 3.6% | 31.8% | 20.0% | 1.1× | 209 |
| GATX | $6.4B | 19.8× | 16.1× | 3.7× | 9.8% | — | 19.2% | 12.1% | 2.2% | 10.5× | 91 |
| GXO | $5.7B | 178.3× | 11.3× | 0.4× | 12.5% | — | 0.2% | 1.1% | 0.5% | 3.1× | 104 |
| GBTG | $5.0B | 43.2× | 18.5× | 1.8× | 12.2% | — | 4.1% | 6.9% | 3.7% | 3.1× | 1 |
| RXO | $4.6B | — | 133.7× | 0.8× | 26.2% | — | -1.7% | -6.5% | -5.1% | 10.5× | 60 |
| BCO | $4.2B | 21.8× | 7.5× | 0.8× | 5.0% | 25.8% | 3.8% | 71.9% | 4.6% | 2.6× | 61 |
| LIND | $2.5B | — | 26.4× | 3.2× | 19.6% | 45.8% | -3.9% | 10.4% | -7.9% | 3.8× | 42 |
| HUBG | $1.6B | 15.7× | 5.4× | 0.4× | -6.1% | — | 2.6% | 6.3% | 5.4% | 0.5× | 45 |
| FWRD | $604M | — | 11.6× | 0.2× | 0.8% | — | -4.3% | -95.1% | -6.0% | 8.4× | 21 |
| VRRM | $508M | 3.9× | 4.2× | 3.8× | 14.6% | — | — | 46.6% | 10.3% | 2.7× | 45 |
| RLGT | $427M | 23.3× | 12.7× | 0.5× | 3.5% | — | 2.0% | 7.8% | 7.8% | -0.8× | 22 |
| OZVN | $73M | — | — | — | -13.5% | 27.9% | -125% | -0.5% | -0.5% | — | — |
Peers = companies sharing OZVN's sector (Transportation Services) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest expense isn't separately reported — often netted into “other income (expense), net.”
Cash vs short-term debt unavailable.
Short-term / long-term split not separately reported.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Educational — not a recommendation.
Solve the discounted cash flow backwards, then stress-test the assumptions.
Average free cash flow across the last 1 positive fiscal year (FY2024). Smooths the cycle. Stock compensation is NOT charged — it is added back inside operating cash flow.
To be worth $2.50 today, the market must believe free cash flow compounds 91.1%/yr for a decade (off $15K on the 3-yr avg basis).
On the basis (-$2.1M) the requirement is off the scale. Shares issued to employees are added back in operating cash flow, so this basis treats them as free.
Default is 9.0% — this company's computed cost of capital (computed WACC), the same rate the Analysis tab discounts at.
2-stage DCF · 0.03B shares (market data) · net debt -$4K
mean -230.4% · volatility σ 46% · implied rate exceeded in 0/2 yrs
Central path = implied 91.1%/yr growth; shaded band = ±1σ (46%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
EOD close · as of 2026-10-28
How a revenue dollar becomes profit — FY2026
Dividends and buybacks are cash paid out, shown here against the same year's profit for scale — not funded from it.
Each value shows its share of revenue below it (common-size).
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $47K 100.0% | $54K 100.0% | $241K 100.0% | $296K 100.0% | $1.1M 100.0% | $1.0M 100.0% | $280K 100.0% | $90K 100.0% | $131K 100.0% |
| Cost of Revenue | $34K 72.1% | $55K 100.8% | $60K 24.7% | $268K 90.6% | $1.1M 102.6% | $899K 89.8% | $229K 81.8% | $74K 81.9% | $132K 101.3% |
| Gross Profit | $13K 27.9% | -$460 -0.8% | $181K 75.3% | $28K 9.4% | -$27K -2.6% | $102K 10.2% | $51K 18.2% | $16K 18.1% | — |
| Selling, General & Admin | $40K 85.2% | $23K 42.5% | $8K 3.3% | $20K 6.6% | $20K 1.9% | $68K 6.8% | $50K 17.9% | $14K 15.1% | $11K 8.1% |
| Total Operating Expenses | $72K 152.9% | $65K 120.1% | $2.7M 1106.0% | $35K 11.9% | $35K 3.3% | $74K 7.4% | $51K 18.2% | $15K 16.2% | $27K 20.4% |
| Pretax Income | -$59K -125.0% | -$66K -121.0% | -$2.5M -1030.7% | -$7K -2.4% | — | — | — | — | — |
| Income Tax Expense | $0 0.0% | $0 0.0% | $0 0.0% | $0 0.0% | -$1K -0.1% | $0 0.0% | $0 0.0% | -$366 -0.4% | $0 0.0% |
| Net Income | -$59K -125.0% | -$66K -121.0% | -$2.5M -1030.7% | -$7K -2.4% | -$68K -6.3% | $28K 2.8% | -$80 -0.0% | $1K 1.5% | -$28K -21.7% |
| Per Share | |||||||||
| EPS (Basic) | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — |
| EPS (Diluted) | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — |
| Weighted Avg Shares (Basic) | 29.4M | 29.4M | 26.3M | 15.6M | — | — | — | — | — |
| Weighted Avg Shares (Diluted) | 29.4M | 29.4M | 26.3M | 15.6M | — | — | — | — | — |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
EOD close · as of 2026-10-28
Where each multiple sits in its own 6-yr range · 62th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 6-yr history.
Is the profit real, and how strong is the balance sheet?
FY2026 · every deduction from revenue to net income
DuPont — the three levers
ROE -0% against ROIC -0% — 0% of the return on equity comes from leverage and buybacks rather than from the operating business.
What the company owes vs. what it holds
This shows debt/cash structure and net leverage. The year-by-year maturity schedule is on the Debt & Leverage tab.
Latest year: profit growth vs revenue growth
Operating leverage needs meaningful revenue change.
Each line as % of revenue — the trend in color
| % of revenue | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 81.9 | 81.8 | 89.8 | 102.6 | 90.6 | 24.7 | 100.8 | 72.1 |
| Gross Profit | 18.1 | 18.2 | 10.2 | -2.6 | 9.4 | 75.3 | -0.8 | 27.9 |
| SG&A | 15.1 | 17.9 | 6.8 | 1.9 | 6.6 | 3.3 | 42.5 | 85.2 |
| Income Tax | -0.4 | 0.0 | 0.0 | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | 1.5 | -0.0 | 2.8 | -6.3 | -2.4 | -1030.7 | -121.0 | -125.0 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on OZVN: price, valuation and headline fundamentals from SEC filings. The four questions at the top of the page are where the judgements live.
No positive operating income in the last three years, so there is no return on capital to compare against its cost.
| Fiscal year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY2018 | -1.3% | not reported | -21.7% |
| FY2019 | 18.1% | not reported | 1.5% |
| FY2020 | 18.2% | not reported | -0.0% |
| FY2021 | 10.2% | not reported | 2.8% |
| FY2022 | -2.6% | not reported | -6.3% |
| FY2023 | 9.4% | not reported | -2.4% |
| FY2024 | 75.3% | not reported | -1030.7% |
| FY2025 | -0.8% | not reported | -121.0% |
| FY2026 | 27.9% | not reported | -125.0% |
Return on equity (-0%) and return on invested capital (-0%) are within a couple of points in FY2026, so the headline return is the operating return — there is no meaningful leverage effect to strip out.
No material counter-signal in the checked set: ROIC vs WACC spread, 5-year spread history, gross margin trend, operating margin trend, net margin against 3 years ago, revenue growth, ROIC ex-goodwill gap.
Missing from our data, so excluded from this answer: positive EBIT.
Fewer than three profitable years with a cash flow statement, so cash conversion cannot be judged.
No material counter-signal in the checked set: FCF / net income over 3 and 5 years, Sloan accruals, SBC as a share of revenue, SBC as a share of operating cash flow, SBC-adjusted free cash flow, free cash flow per diluted share, buybacks against SBC issued, capex vs depreciation, free cash flow against revenue, share count since the first year on file, cash conversion cycle (DSO, DIO, DPO), receivables growth against revenue growth.
Missing from our data, so excluded from this answer: 3 years of cash flow.
No debt, so there is no leverage path to distress.
Balance sheet at 2026-06-30. Undrawn revolving credit is not shown: the tag is collected but not yet mapped through to the API.
No material counter-signal in the checked set: net debt / EBITDA, interest coverage, stressed coverage, maturity schedule vs cash and one year of FCF, liquidity ratios.
At $2.50, free cash flow must compound 91.06%/yr for 10 years. It has no positive compounding record to compare against.
The implied rate of 91.06% has not been achieved in any of the last 1 years.